Targeted therapy of inflammatory bowel diseases: realities and prospects

Медицинский совет

I. V. Maev¹  D. N. Andreev¹ 

[1] A.I.Yevdokimov Moscow State University of Medicine and Dentistry of the Ministry of Health of Russia;

关键词: inflammatory bowel disease;    crohn’s disease;    ulcerative colitis;    targeted therapy;    biological therapy;    infliximab;    adalimumab;    golimumab;    cetrolizumab;    tofacinib;    filgotinib;    ustkinumab;    natalizumab;    vedolizumab;   

DOI  :  10.21518/2079-701X-2018-6-114-118

来源: DOAJ

【 摘 要 】

This review article was designed to systematize the literature data concerning the role of targeted therapy in the treatment of patients with inflammatory bowel diseases. It presents the data of the latest randomized clinical trials and meta-analyses evaluating the efficacy and safety of targeted drugs for the treatment of Crohn’s disease and ulcerative colitis.

【 授权许可】

Unknown